Jennifer N. Clements, PharmD, BPCS, CDE, BCACP, reviews some details of the reports of ketocacidosis with the use of SGLT2 inhibitors.

All articles by Jennifer Clements, PharmD, BCPS, CDE, BCACP
One study demonstrating increased mortality among patients with type 1 diabetes implicates the importance of glycemic control.
Publish Date
Reflections on the drug may raise questions about when to use pramlintide in diabetes.
Publish Date
Jennifer N. Clements, PharmD, BCPS, CDE, BCACP, discusses the pros and cons of liraglutide as a new therapy for weight management.
Publish Date
A new ADA and EASD position statement along with the ADA’s revised Standards of Medical Care in Diabetes have surprising updates.
Publish Date
Evidence shows that the maximum dose of Qsymia is effective for obese patients with type 2 diabetes, but clinicians should still consider all factors.
Publish Date
-
Latest News Your top articles for Thursday
For More Personalized News -
Haymarket Medical NetworkTop Picks
- Loading...
Continuing Medical Education (CME/CE) Courses